In addition, in the presence of Gefitinib, residual PLC-γ1(S1248) levels were approximately two-fold higher than those during mock infection, and Gefitinib could not completely extinguish virus infection (Figure 5). The gene discussed is PLCG1; the disease is viral infectious disease.